Leonard Sank - 05 Jun 2025 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Director
Signature
/s/ Leonard Sank
Issuer symbol
ORMP
Transactions as of
05 Jun 2025
Net transactions value
$0
Form type
4
Filing time
09 Jun 2025, 16:07:47 UTC
Previous filing
08 Jan 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sank Leonard Director 3 BLAIR ROAD, CAPE TOWN, SOUTH AFRICA /s/ Leonard Sank 09 Jun 2025 0001416089

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +30,000 +31% 128,021 05 Jun 2025 Direct F1
transaction ORMP Common Stock Award +6,510 +5.1% 134,531 05 Jun 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that will vest in equal portions of 10,000 as follows: January 1, 2026, January 1, 2027 and January 1, 2028. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
F2 Represents RSUs that will vest in equal installments as follows: on grant, July 1, 2025, October 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.